TANNER WOOLF: Open Payments
NPI 1346994001 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,425 in 82 payments from 16 companies in 2025. Trend: 2023 $528 · 2024 $202 · 2025 $1,425
Food & beverage: $1,425
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $346 |
| Madrigal Pharmaceuticals | 14 | $319 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $189 |
| Regeneron Healthcare Solutions, Inc. | 8 | $139 |
| GENZYME CORPORATION | 6 | $125 |
| PFIZER INC. | 4 | $62 |
| Celltrion USA Inc. | 3 | $58 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Intercept Pharmaceuticals, Inc. | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
Products named: REZDIFFRA, DUPIXENT, RINVOQ, ENTYVIO, EOHILIA, CREON, VEGZELMA, VELSIPITY.
Industry payments across ID — which companies pay providers there.
